Schmidt et al. reported immunohistochemically detectable expression of ROCK’s upstream regulator RhoA to occur in >90% of prostate cancers and described a link between high level RhoA expression to large tumor size and poor prognosis [20]. This evidence concerns the gene RHOA and neoplasm.